American Journal of Bioavailability & Bioequivalence (AJBB) is an open access reviewed online publishing journal which intends to publish scholarly and quality papers in all aspects of Bioequivalence, Bioequivalence anticancer, Bioequivalence antidiuretics, Bioequivalence antipsychotics, Advances in Bioavailability.

Bioavailability is a term used in pharmacology, nutritional and environmental sciences which bring up to the degree and rate at which an administered drug that reaches the systemic circulation, it is also one of the principal pharmacokinetic properties of drugs. Bioequivalence is a term used in pharmacokinetics to evaluate the two drugs release their active ingredient into the bloodstream in the same amounts and at the same rate, assessing how well a generic drug works.

The scope of the journal highlights on all areas of Pharmacokinetics, Pharmacodynamics, Bioavailability, Drug delivery, Drug discovery, Drug metabolism, Sample preparation for analysis, etc.

Article Types

American Journal of Bioavailability & Bioequivalence publishing Original research articles, clinical trials, Reviews, Case reports, Editorials, Letter to the editor, Short communication, Opinion, Book review, commentaries, Short reviews and other special featured articles related to all aspects of Bioavailability & Bioequivalence.

The target audience of the journal includes, pharmacologists, research scholars, and all other health professionals, researchers, professors who are interested in these topics.

Please share your manuscript through online platform: online submission or as an E-mail attachment to the Editorial Office at bioavailability@scireslit.com (or) bioequivalence@scireslit.com